Evidence map›Paper›PMID 39071222›Full record

ArticleHardwareX2024

The Open SprayBot: A high-throughput paper spray mass spectrometry platform for disease screening.

Nancy Shyrley García-Rojas, Héctor Guillén-Alonso, Scott MacKay, Claudia Torres-Calzada, Leonardo Daniel Soto-Rodriguez, Robert Winkler, David S Wishart

Abstract read
In one paragraph

Article in HardwareX, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nancy Shyrley García-RojasLaboratorio de Análisis Bioquímico e Instrumental, Unidad de Genómica Avanzada, Cinvestav, Km. 9.6 Libramiento Norte, Carretera Irapuato-León, Irapuato, Guanajuato, México.
Héctor Guillén-AlonsoLaboratorio de Análisis Bioquímico e Instrumental, Unidad de Genómica Avanzada, Cinvestav, Km. 9.6 Libramiento Norte, Carretera Irapuato-León, Irapuato, Guanajuato, México.
Scott MacKayDepartment of Biological Science, University of Alberta, Edmonton, Canada.
Claudia Torres-CalzadaDepartment of Biological Science, University of Alberta, Edmonton, Canada.
Leonardo Daniel Soto-RodriguezLaboratorio de Análisis Bioquímico e Instrumental, Unidad de Genómica Avanzada, Cinvestav, Km. 9.6 Libramiento Norte, Carretera Irapuato-León, Irapuato, Guanajuato, México.
Robert WinklerLaboratorio de Análisis Bioquímico e Instrumental, Unidad de Genómica Avanzada, Cinvestav, Km. 9.6 Libramiento Norte, Carretera Irapuato-León, Irapuato, Guanajuato, México.
David S WishartDepartment of Biological Science, University of Alberta, Edmonton, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Newborn disease screening increases survival, improves quality of life and reduces treatment costs for healthcare systems. Mass spectrometry (MS) is an effective method for metabolic screening. However, conventional analytical methods require biofluid handling and cooling conditions during transport, making the logistics difficult and expensive, especially for remote regions. 'Paper-spray' (PS) ionization generates a charged solvent spray from samples deposited on paper strips. Therefore, samples can be applied on a suitable matrix and shipped as dried spots to diagnostic laboratories with standard postal or messenger services. We built a robotic platform, the 'Open SprayBot', to automatically analyze paper-deposited samples via PS-MS and increase the sample throughput. The system is operated via RUMBA32 and Arduino Mega boards. A commercial syringe pump and power supply provide solvent application and electrical current required for PS-MS. The usability of the Open SprayBot was demonstrated by quantifying palmitoyl-l-carnitine, a common biomarker in newborn screening.

Indexed as

3D-printingHigh-throughputOpen-sourcePaper-spray mass spectrometry

Identifiers

PMID39071222
PMCPMC11283016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.